Author

K. Raikhelson

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Fatigue, weakness, and sleep disturbances in liver disease: Diagnosis and patient management

Fatigue/weakness in chronic liver diseases is a clinically significant symptom that goes beyond subjective discomfort and requires separate clinical assessment. Available data indicate that fatigue/weakness affects quality of life, daily activities, and prognosis, while more pronounced fatigue/weakness at baseline is i...

K. Raikhelson, M. G. Poluektov, D. Petelin et al. · Meditsinskiy sovet = Medical... · 0 citations

Open access Oct 2026

Metabolic-associated fatty liver disease and hypertriglyceridemia: cardiovascular risks and current therapeutic approaches

Metabolic-associated fatty liver disease (MAFLD) is a systemic disorder associ-ated with metabolic dysfunction and a high risk of life-threatening conditions, primarily cardiovascular disease. MAFLD is often accompanied by hypertriglyceridemia (HTG), as both conditions share a common pathogenetic mechanism — insulin re...

Y. Khalimov, M. Yezhov, K. Raikhelson et al. · Russian Journal of Cardiolog... · 0 citations

Review Open access Sep 2026

Fixed-Dose Combinations of Glycyrrhizic Acid + Phospholipids and Glycyrrhizic Acid + Ursodeoxycholic Acid in the Treatment of Non-Alcoholic Fatty Liver Disease (Literature Review and Expert Council Resolution)

Aim: to evaluate, based on an analysis of preclinical and clinical data, the efficacy and safety of fixed combinations of glycyrrhizic acid with phospholipids or ursodeoxycholic acid for the treatment of non-alcoholic fatty liver disease. Key points. Glycyrrhizic acid exerts antisteatotic, anti-inflammatory, and a...

S. Okovityi, K. Raikhelson, A. O. Bueverov et al. · Russian Journal of Gastroent... · 0 citations